Famotidine
"Famotidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Descriptor ID |
D015738
|
| MeSH Number(s) |
D02.886.675.215 D03.383.129.708.215
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Famotidine".
Below are MeSH descriptors whose meaning is more specific than "Famotidine".
This graph shows the total number of publications written about "Famotidine" by people in this website by year, and whether "Famotidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Famotidine" by people in Profiles.
-
Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs. Dig Dis Sci. 1997 Apr; 42(4):707-14.
-
Fish DN. Safety and cost of rapid i.v. injection of famotidine in critically ill patients. Am J Health Syst Pharm. 1995 Sep 01; 52(17):1889-94.